Quarter Financials
Adaptimmune Therapeutics plc (ADAP)
$2.38
+0.13 (+5.78%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Net Income | -45 | -50 | -38 | -42 | -39 | -38 | -37 | -35 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -839 | -794 | -744 | -705 | -663 | -624 | -586 | - |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Capital Expenditure | -9 | -7 | - | -2 | -2 | -1 | -1 | -1 |
|---|
| Net PPE | 65 | 58 | 51 | 50 | 46 | 46 | 47 | 46 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| New Purchases | -66 | -17 | -62 | -20 | 1 | - | -42 | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|